Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

PSNC arms contractors with defence from GP flu 'negativity'

The negotiator’s director of NHS services Alastair Buxton says pharmacists should use a PSNC briefing document to “correct factual inaccuracies” about the national flu initiative

The Pharmaceutical Services Negotiating Committee (PSNC) has published rebuttals for contractors to use against “vocal” GPs opposed to the national flu service.

The negotiating body said it has heard from a “number of LPCs” that have experienced “negativity” from local GPs regarding the national flu vaccination service, announced in the 2015-16 pharmacy funding settlement.

In its briefing document, published last Friday (August 7), PSNC addresses GP concerns with the perceived lack of warning about the new service and the risk that it could lead to vaccination shortages. 

The document was not designed to “encourage confrontation”, but should be used to “correct any factual inaccuracies and try to persuade both [GPs] and patients of the benefits” of the service, ​said PSNC director of NHS services Alastair Buxton.

Mr Buxton said the negative reaction from some GPs is “sad”, but “not unexpected”.

“GP support is not necessary for the service to succeed. However, we would encourage pharmacists and LPCs to try to engage constructively where GPs are raising concerns,” he said.

If GPs argue that the national service will alter their own vaccination plans, pharmacists should point out that only two of NHS England’s area teams did not commission a local pharmacy flu service last year, PSNC said. “Although this is a new advanced service, in reality it is not a huge change in commissioning activity,” it said in the briefing document.

"Low" risk of double vaccinations

The perceived risk of patients receiving two vaccinations because of record-keeping issues is also “low”, and there is “no evidence” that pharmacies will “cherrypick” the easiest patients, PSNC stressed.

“Pharmacies have more regular contact with many vulnerable people and their carers than any other healthcare professionals, so it is likely [they] will reach patients who would not otherwise be vaccinated,” it said.

Contractors and their teams are “keen” to get themselves “as ready as possible to deliver the service”, which is due to start in September, PSNC said.

The negotiator has also produced a leaflet to “specifically target common issues and tackle misconceptions” among patients, it added. The leaflet addresses a number of myths about the sector's ability to deliver the service, including the mistaken belief that pharmacists cannot offer flu vaccinations in private.

Last month, pharmacy leaders issued a defiant response to criticism from leading GPs that a national pharmacy flu service will fail to boost vaccine uptake.  

 

Have you experienced any negativity from GPs towards the service? 
 

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007616

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel